NUPLAZIDCONNECT

WIPO WIPO 2016

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark NUPLAZIDCONNECT was filed as Word mark on 10/26/2016 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1360925
Countries Australia Switzerland China em United Kingdom India Japan Mexico Turkey
Base trademark US No. 87013993, April 26, 2016
Application date October 26, 2016
Expiration date October 26, 2026

Trademark owner

12830 El Camino Real,
Suite 400
US

Trademark representatives

1299 PENNSYLVANIA AVENUE, SUITE 700 WASHINGTON DC 20004 US

goods and services

16 Publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of medical information and patient support
35 Promoting awareness of patient support offerings for neurologic, metabolic, and genetic diseases and disorders; business administration of reimbursement and medical benefit information for neurologic, metabolic and genetic conditions and their treatment
36 Providing financial information regarding medical benefits and reimbursements available for medical expenses related thereto, via a website; insurance services, namely, benefits verification; providing online information for health care providers and patients in the field of neurologic, metabolic and genetic diseases and disorders, namely information and assistance with insurance benefits and coverage
41 Educational services, namely, conducting educational programs about neurologic, metabolic, and genetic diseases and disorders and treatment and patient support options for these conditions
44 Medical consulting with respect to neurologic, metabolic, and genetic conditions and their treatment; providing online information for health care providers and patients in the field of neurologic, metabolic and genetic diseases and disorders; medical informational support services, namely, providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals all related to neurologic, metabolic and genetic diseases and disorders; medical referrals

Trademark history

Date Document number Area Entry
November 8, 2018 2018/46 Gaz TR Rejection
August 9, 2018 2018/35 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 11, 2018 2018/28 Gaz CH Rejection
July 5, 2018 2018/27 Gaz MX Rejection
June 21, 2018 2018/25 Gaz CN Rejection
March 1, 2018 2018/9 Gaz JP Rejection
January 19, 2018 2018/4 Gaz EM Rejection
January 8, 2018 2018/2 Gaz IN Rejection
November 29, 2017 2017/48 Gaz AU Rejection
November 22, 2017 2017/47 Gaz GB Rejection
October 26, 2016 2017/31 Gaz US Registration

ID: 141360925